Purchases and Sales Made in Q1 2024 in 10x Genomics, Inc. (TXG)
This table provides information about the institutional ownership of 10x Genomics, Inc. (TXG) during Q1 2024. The information is specifically focused on institutions that hold shares of 10x Genomics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 01, 2024
Q1 2024
|
Baillie Gifford & CO
|
SELL
|
- |
-495K- 6.25% |
$17.9M - $26.9M
|
7.42M
$89.8M
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-609K- 10.55% |
$22M - $33.1M
|
5.16M
$62.5M
|
|
|
May 15, 2024
Q1 2024
|
Brown Capital Management LLC
Baltimore, MD |
SELL
|
- |
-852K- 24.17% |
$30.8M - $46.3M
|
2.67M
$32.4M
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.4M- 94.62% |
$50.4M - $75.8M
|
79.4K
$961K
|
|
|
May 14, 2024
Q1 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-2.25M- 96.41% |
$81.2M - $122M
|
83.8K
$1.01M
|